AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (10726 Reviews)

New fund investing used to be intimidating. KSquare’s support and transparency made it not only easy but enjoyable. I now look forward to NFOs!

Ashwin Nambiar

Ashwin Nambiar

Logistics Planner

I was looking for a secure retirement plan, and KSquare’s NPS guidance made it very easy to start.

Richa Mahajan

Richa Mahajan

HR Advisor

Thanks to KSquare’s New Fund Offering alerts, I’ve been able to catch early opportunities that matched my long-term strategy and risk appetite.

Nilesh Arora

Nilesh Arora

Sales Strategist

Navigating investments from Canada was overwhelming until I used KSquare’s NRI services. They simplified the entire process beautifully.

Nisha Kapoor

Nisha Kapoor

Corporate Trainer

Starting SIPs with KSquare has brought so much clarity to my finances. Their platform is smooth, and the investment returns speak for themselves.

Meera Iyer

Meera Iyer

Data Analyst

KSquare’s SIP plans align perfectly with my monthly savings goals. I appreciate how effortless the process is. It's really helped me become financially disciplined.

Ananya Joshi

Ananya Joshi

Interior Designer

KSquare’s NPS support was practical and transparent. They helped me compare options and choose what’s best for my future.

Naveen Thakkar

Naveen Thakkar

Chartered Accountant

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

KSquare offered expert financial advice tailored to NRI needs. Their responsive team and secure platform earned my trust right away.

Rajat Verma

Rajat Verma

Software Architect

I’ve used a few platforms before, but KSquare is easily the most user-centric. Their mutual fund tools make planning easy and returns trackable.

Ketan Ghosh

Ketan Ghosh

Export Manager

FAQ's

Frequenlty Asked Question

Does KSquare offer mutual funds for tax savings?

Yes, KSquare offers ELSS mutual funds, which are eligible for tax deductions under Section 80C up to ₹1.5 lakh.

Can I withdraw funds from my NPS account early?

Partial withdrawals of up to 25% are allowed after 3 years for specific purposes like medical emergencies, education, or house purchase.

Are NFOs safe for first-time investors?

NFOs can be suitable for beginners, but they carry risks. KSquare helps assess fund strategies before you commit.

What documents are needed for applying LAMF?

Basic KYC documents, bank statements, and demat account details are required. KSquare helps with digital submission.

How much loan can I get against mutual funds?

You can typically borrow up to 50–70% of your mutual fund’s NAV value. KSquare calculates this during your application.

Is NPS a market-linked investment?

Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.

What types of accounts are required for NRI investments?

NRIs need either an NRE or NRO account to start investing through KSquare, depending on fund repatriation needs.

What if I need money before my SIP goal time?

Some SIP funds offer liquidity options, allowing partial withdrawals whenever required without disturbing the entire investment plan.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.